Cadence Neuroscience

About:

Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.

Website: http://www.cadenceneuro.com/

Top Investors: F-Prime Capital, Mayo Clinic, LivaNova, Jazz Venture Partners, Mayo Clinic Ventures

Description:

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Total Funding Amount:

$41M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Redmond, Washington, United States

Founded Date:

2017-01-01

Founders:

Doug Sheffield, Kent Leyde

Number of Employees:

11-50

Last Funding Date:

2023-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai